FOLD

FOLD EBITDA Margin

8.48%TTM

Period ending:

FOLD FY EBITDA Margin%
FOLD FY EBITDA Margin2038.59%-18939.20%
2003-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

FOLD ebitda margin history

EBITDA as a percentage of revenue. The available annual fiscal periods series contains 23 observations from Dec 31, 2003 to Dec 31, 2025.

Amicus Therapeutics Inc EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
8.4846%
5.563%
-23.0569%
-60.6191%
-66.4042%
-93.1376%
-182.3247%
-353.4122%
-1,159.7292%
-3,935.8814%
0%
-5,474.5098%
-16,909.0909%
-272.8586%
-217.1223%
-5,830.4772%
-6.4592%
-251.5133%
-2,498.2063%
0%
0%
0%
0%

Compare ebitda margin

All FOLD financial metrics · FOLD stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.